Value of PET /CT and diagnostic CT scan in differentiated thyroid carcinoma patients with high serum thyroglobulin and negative 131I whole body scan
Main Article Content
Abstract
Objective: to determine value of FDG-PET/CT and diagnostic CT scan in post-surgical differentiated thyroid carcinoma patients
with high serum thyroglobulin and negative 131I whole body scan.
Patients and method: We performed FDG-PET/CT and diagnostic CT scan in 49 post-surgical differentiated thyroid carcinoma patients with high serum thyroglobulin and negative 131I whole body scan who already underwent 131I therapy in Department
of Nuclear Medicine, 108 Central Military Hospital.
Results: 41 lesions detected in 29/49 patients (59.2%) with positive PET/CT scan compared to only 20 lesions 18/49 patients
(36.7%) detected on positive CT scan. The Sn, Ac and NPV of FDG-PET/CT were 83.9%, 83.7% and 75% higher than those of CT
(51.6%, 65.3% and 51.6%, respectively). Sp and PPV of FDG-PET/ CT (83.3% and 89.7%, respectively) were similar to those of CT
(88.9%). SUVmax thresholds with good diagnostic value were 4.5 (Sn 84.6%, Sp 66.7%) and 5.0 ( Sn 65.3%, Sp 100%). FDG-PET/CT
had altered treatment plan in 25/49 patients (51.2%).
Conclusion: FDG-PET/CT is superior than CT in detecting reccurent/metastatic lesions in post-surgical differentiated thyroid
carcinoma patients with high serum thyroglobulin and negative 131I whole body scan.
Article Details
Keywords
FDG PET/CT, CT, differentiated thyroid carcinoma
References
2. Lê Duy Hưng và cs (2009), Nghiên cứu một số đặc điểm lâm sàng và đánh giá kết quả điều trị bằng 131I ở BN di căn do UT tuyến giáp thể biệt hóa sau phẫu thuật, Tạp chí Y dược lâm sàng 108, tập 4, tr 93-99.
3. Altenvoerde G et al (1998), Positron emission tomography with F-18-deoxy glucose in patients with differentiated thyroid carcinoma, elevated thyroglobin levels, and negative iodine scans, Langenbecks Arch Surg, 383, pp 160-3.
4. Atkins FB, Van Nostrand D (2006), Radioiodine Whole Body Imaging, Thyroid Cancer a comprehensive guide to clinical management, Second edition, Humana Press, pp 133-50.
5. Baudin E et al (2003), Positive predictive value of serum thyroglobulin levels, mesured during the first year of follow-up after thyroid hormon withdrawal, in thyroid cancer patients, J Clin Endocrinol Metab, 88, pp 1107-11.
6. Chung JK et al (1999), Value of FDG PET in papillary thyroid carcinoma with negative 131I Whole-Bogy Scan, J Nucl Med, 40, pp 986-92.
7. David SC et al (2009), Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, 19(11), pp 1167-214.